304 related articles for article (PubMed ID: 2675617)
21. Relation of follicular dendritic reticulum cells to Reed-Sternberg cells of Hodgkin's disease with emphasis on the expression of CD21 antigen.
Delsol G; Meggetto F; Brousset P; Cohen-Knafo E; al Saati T; Rochaix P; Gorguet B; Rubin B; Voigt JJ; Chittal S
Am J Pathol; 1993 Jun; 142(6):1729-38. PubMed ID: 7685151
[TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
Doussis-Anagnostopoulou IA; Talks KL; Turley H; Debnam P; Tan DC; Mariatos G; Gorgoulis V; Kittas C; Gatter KC
J Pathol; 2002 Aug; 197(5):677-83. PubMed ID: 12210089
[TBL] [Abstract][Full Text] [Related]
23. [Pathology of Hodgkin's lymphoma].
Hansmann ML; Willenbrock K
Verh Dtsch Ges Pathol; 2003; 87():53-7. PubMed ID: 16888894
[TBL] [Abstract][Full Text] [Related]
24. [The immunological characterization of 63 cases of Hodgkin's disease with a panel of 8 antibodies].
Oliva-Aldamiz H; Echezarreta G; Aguilera B; Cuevas E; Barat A; Sarasa JL; Renedo G; Rivas F; Forteza J; Sánchez-Fayos MP
Rev Clin Esp; 1992 Mar; 190(5):229-37. PubMed ID: 1374567
[TBL] [Abstract][Full Text] [Related]
25. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
[TBL] [Abstract][Full Text] [Related]
26. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical determination of CD23 expression in Hodgkin's disease using paraffin sections.
Rowlands DC; Hansel TT; Crocker J
J Pathol; 1990 Mar; 160(3):239-43. PubMed ID: 2139890
[TBL] [Abstract][Full Text] [Related]
28. Immunoreactivities of Reed-Sternberg cells and their variants in the sequential biopsy of Hodgkin's disease.
Ohsawa M; Aozasa K; Ikeda H
Mod Pathol; 1993 Jul; 6(4):457-62. PubMed ID: 8415592
[TBL] [Abstract][Full Text] [Related]
29. Rosetting and other reactions of the Reed-Sternberg cell.
Stuart AE; Williams AR; Habeshaw JA
J Pathol; 1977 Jun; 122(2):81-90. PubMed ID: 327044
[TBL] [Abstract][Full Text] [Related]
30. [Hodgkin's nodular paragranuloma (nodular Hodgkin's disease, with lymphocytic predominance): apropos of 29 cases].
Molina T; Diebold J
Bull Cancer; 1987; 74(4):463-72. PubMed ID: 3663967
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic expression of Hodgkin's and Reed-Sternberg cells in Hodgkin's disease.
Hsu SM; Yang K; Jaffe ES
Am J Pathol; 1985 Feb; 118(2):209-17. PubMed ID: 3970138
[TBL] [Abstract][Full Text] [Related]
32. Immunological markers of peripheral blood and lymph node lymphocytes in Hodgkin's disease.
González M; Hernández F; San Miguel JF; Moraleda JM; Caballero MD; López Borrasca A
Neoplasma; 1985; 32(2):191-8. PubMed ID: 4000308
[TBL] [Abstract][Full Text] [Related]
33. The patterns of IL2, IFN-gamma, IL4 and IL5 gene expression in Hodgkin's disease and reactive lymph nodes are similar.
Serrano D; Ghiotto F; Roncella S; Airoldi I; Cutrona G; Truini M; Burgio VL; Baroni CD; Ferrarini M; Pistoia V
Haematologica; 1997; 82(5):542-9. PubMed ID: 9407718
[TBL] [Abstract][Full Text] [Related]
34. B- and T-lymphocytes in Hodgkin's disease. An immunohistochemical study utilizing heterologous and monoclonal antibodies.
Forni M; Hofman FM; Parker JW; Lukes RJ; Taylor CR
Cancer; 1985 Feb; 55(4):728-37. PubMed ID: 3155642
[TBL] [Abstract][Full Text] [Related]
35. T and B lymphocytes and Reed-Sternberg cells in Hodgkin's disease lymph nodes and spleens.
Payne SV; Jones DB; Haegert DG; Smith JL; Wright DH
Clin Exp Immunol; 1976 May; 24(2):280-6. PubMed ID: 1084241
[TBL] [Abstract][Full Text] [Related]
36. Coexisting Hodgkin's disease and mycosis fungoides. Immunohistochemical proof of its existence.
Simrell CR; Boccia RV; Longo DL; Jaffe ES
Arch Pathol Lab Med; 1986 Nov; 110(11):1029-34. PubMed ID: 3096258
[TBL] [Abstract][Full Text] [Related]
37. Significance of cell proliferation index in assessing histological prognostic categories in Hodgkin's disease. An immunohistochemical study with Ki67 and MIB-1 monoclonal antibodies.
Abele MC; Valente G; Kerim S; Navone R; Onesti P; Chiusa L; Resegotti L; Palestro G
Haematologica; 1997; 82(3):281-5. PubMed ID: 9234572
[TBL] [Abstract][Full Text] [Related]
38. Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease.
Rysenga E; Linden MD; Carey JL; Ross CW; Schnitzer B; Sawdyk M; Maeda K
Arch Pathol Lab Med; 1995 Jan; 119(1):88-91. PubMed ID: 7802562
[TBL] [Abstract][Full Text] [Related]
39. Hodgkin's disease with coexistent Castleman-like histologic features. A report of three cases.
Zarate-Osorno A; Medeiros LJ; Danon AD; Neiman RS
Arch Pathol Lab Med; 1994 Mar; 118(3):270-4. PubMed ID: 8135630
[TBL] [Abstract][Full Text] [Related]
40. Nodular and diffuse types of lymphocyte predominance Hodgkin's disease.
Regula DP; Hoppe RT; Weiss LM
N Engl J Med; 1988 Jan; 318(4):214-9. PubMed ID: 3336412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
